^1.  Based on self-reported data by 645 patients, over the period of Jan 2024 to Apr 2025, patients who were prescribed GLP-1 medication experienced on average weight loss of 9.6 pounds in the first 30 days. Get Thin MD does not guarantee that your results will match those of patients represented in this sample data. Individual weight loss outcomes may vary based on numerous personal factors.

*The assessment made available on the Get Thin MD website does not create a doctor-patient relationship between the individual completing the assessment and Get Thin MD. OpenLoop Health, a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the Get Thin MD assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and an OpenLoop Health clinician will meet with an individual after checkout to determine if they qualify for a prescription. OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients.
All claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire every 3-4 weeks thereafter. Results from compounded medications found on the Get Thin MD platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations. Compounded GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and medical history.
We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. Get Thin MD does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.

Pharmacy ProvidersWe are partnered with multiple USA certified pharmacies to bring the best product and overall experience to our membership. Our team meets regularly with pharmacies to discuss any product shortages, shipping delays, and get updated reports on their medication testing.

Medication is included in the cost of the Get Thin MD Program. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss. The trademarks, service marks, trade names (Wegovy® ,Ozempic®), and products displayed on this Internet site are protected and belong to their respetive owners. Medical treatment is provided by “CareGLP Affiliated P.C.s,” and OpenLoop Health, affiliated networks for medical professional corporations and associations. No data, photos, claims or any other information is associated with results derived from clinical trials, studies or public information and is always representative of Get Thin MD patient experience.


Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

The FDA does not review. compounded medications for safety or efficacy. GetThinMD does not manufacture or dispense medications. GetThinMD connects patients with licensed healthcare providers who may prescribe treatments based on individual eligibility. This product is available by prescription only. Individual results may vary. Bottle used for visual purposes only. Safety information may be found at https://www.getthinusa.com/important-safety-information